Mobic

Approved Indications

Mobic is primarily used to manage the symptoms of chronic joint conditions that involve inflammation. It works by reducing the hormones in the body that cause pain and swelling.

Osteoarthritis

Mobic is prescribed to relieve the signs and symptoms of osteoarthritis. This is a degenerative joint disease that occurs when the protective cartilage on the ends of bones wears down over time, leading to pain and stiffness.

Rheumatoid Arthritis

This medication is used to treat rheumatoid arthritis, an autoimmune disorder. In this condition, the immune system attacks the joints, causing painful swelling that can eventually result in bone erosion and joint deformity.

Juvenile Rheumatoid Arthritis

Mobic is also indicated for the treatment of juvenile rheumatoid arthritis in children who are at least 2 years of age. It helps reduce joint pain and inflammation in pediatric patients, helping to maintain mobility and physical function.

Mechanism of Action

Mobic belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the activity of enzymes called cyclooxygenase (COX). These enzymes are responsible for creating prostaglandins, which are hormone-like substances that the body produces in response to injury or certain diseases.

Prostaglandins play a major role in the body's inflammatory response. When they are released, they cause:

• Swelling and redness in the tissues.
• Increased sensitivity to pain.
• Fever.

By blocking the enzymes that create these substances, Mobic reduces the level of prostaglandins in the body. This leads to a decrease in inflammation, which helps relieve joint pain, stiffness, and swelling associated with conditions like arthritis. Because it targets the underlying chemical signals of pain rather than just masking the sensation, it is often used for the management of chronic inflammatory symptoms.

Common Side Effects

Some individuals may experience mild side effects while taking Mobic. These symptoms often include:

• Diarrhea, constipation, or gas
• Nausea, vomiting, or upset stomach
• Dizziness
• Headache
• Cold-like symptoms, such as a sore throat or runny nose

Serious Side Effects

Stop taking this medication and seek emergency medical help immediately if you experience any of the following serious symptoms:

Allergic and Skin Reactions

• Signs of an allergic reaction, including hives, swelling of the face, lips, or throat, and difficulty breathing
• Severe skin reactions, such as skin pain, fever, and a red or purple rash that spreads and causes blistering or peeling

Cardiovascular and Neurological Warning Signs

• Chest pain that may spread to the jaw or shoulder
• Shortness of breath
• Sudden numbness or weakness, especially on one side of the body
• Slurred speech or sudden vision changes

Gastrointestinal and Organ Problems

• Signs of stomach bleeding, such as black, bloody, or tarry stools, or coughing up blood or vomit that looks like coffee grounds
• Liver issues, including yellowing of the skin or eyes (jaundice), dark urine, and severe nausea or upper stomach pain
• Kidney problems, such as little or no urination or swelling in the feet and ankles
• Rapid weight gain

Cardiovascular Risks

Nonsteroidal anti-inflammatory drugs (NSAIDs) like Mobic may increase the risk of serious cardiovascular thrombotic events, including heart attack and stroke, which can be fatal. This risk may occur early in treatment and may increase with longer duration of use. Mobic is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Gastrointestinal Risks

NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and those with a prior history of peptic ulcer disease or GI bleeding are at a higher risk for serious GI events.

Allergic Reactions

Mobic should not be taken by individuals who have experienced asthma, hives, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions have been reported in such patients.

Organ Health and Monitoring

• Kidney Function: Long-term use of NSAIDs can result in kidney injury. Mobic is not recommended for patients with advanced kidney disease.
• Liver Function: Elevations of liver enzymes may occur. Treatment should be discontinued if clinical signs and symptoms of liver disease develop or if systemic manifestations occur.
• Hypertension: Mobic can lead to the onset of new high blood pressure or worsening of pre-existing high blood pressure, which may contribute to cardiovascular events.

Pregnancy and Fertility

Use of Mobic during pregnancy can cause harm to the unborn baby. It should be avoided starting at 30 weeks of pregnancy as it may cause premature closure of the fetal ductus arteriosus. Use at 20 weeks or later may cause fetal kidney problems leading to low amniotic fluid. Additionally, NSAIDs may delay or prevent ovulation, which can affect fertility in people assigned female at birth.

Severe Skin Reactions

Mobic can cause serious skin adverse events such as exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN), which can be fatal. These events may occur without warning.

Pregnancy

Mobic belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Taking NSAIDs at 20 weeks of pregnancy or later can cause rare but serious kidney problems in an unborn baby, which may lead to low levels of amniotic fluid.

Use of this medication is specifically discouraged starting at 30 weeks of pregnancy. At this stage, it can cause the premature closure of the ductus arteriosus, a blood vessel in the baby's heart, which can lead to heart and lung complications in the newborn.

For individuals trying to conceive, Mobic may delay or prevent ovulation. This effect is generally temporary and stops after the medication is discontinued.

Breastfeeding

There is limited information regarding the presence of meloxicam in human breast milk. It is not known if the drug affects milk production or if it poses a risk to a breastfeeding infant. Healthcare providers usually weigh the benefits of the medication for the mother against the potential risks to the infant when deciding on its use during lactation.

Available Forms

Mobic is primarily supplied as a tablet for oral use. Other versions of the active ingredient, meloxicam, may be available in different formats depending on the manufacturer and the specific condition being treated.

• Oral Tablet: The standard solid form of Mobic taken by mouth.
• Oral Capsule: A form of the medication contained within a shell.
• Oral Suspension: A liquid version of the medication often used for patients who have difficulty swallowing pills.
• Injection: A liquid solution administered by a healthcare professional, typically in a clinical setting.

FDA Approval and Indications

Mobic is an FDA-approved nonsteroidal anti-inflammatory drug (NSAID). It is indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis in adults. It is also approved for use in pediatric patients aged 2 years and older for the treatment of juvenile rheumatoid arthritis.

Boxed Warning

Mobic carries a boxed warning, the most serious type of warning required by the FDA, highlighting significant safety risks:

• Cardiovascular Thrombotic Events: NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, including heart attack and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use.
• Gastrointestinal Bleeding, Ulceration, and Perforation: NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms.

Veterinary Safety Information

The FDA has issued specific warnings regarding meloxicam use in animals. A boxed warning on veterinary labels states that repeated use of meloxicam in cats has been associated with acute renal failure and death.

Dispensing Requirements

Mobic is a prescription-only medication. The FDA requires that a Medication Guide be dispensed with every prescription to ensure patients are aware of the risks of cardiovascular and gastrointestinal events.

Generic vs. Brand Name

Mobic is the brand name for the medication meloxicam. Generic versions of meloxicam are widely available and are typically significantly less expensive than the brand-name product. Most healthcare providers and insurance companies recommend the generic version to help manage costs.

Insurance and Coverage

The amount you pay for Mobic depends largely on your insurance coverage. Generic meloxicam is commonly covered by most insurance plans, including Medicare Part D, often with a low copayment. Brand-name Mobic may be subject to higher out-of-pocket costs or may require prior authorization from your insurance provider.

Additional Cost Factors

• Pharmacy Selection: Prices can vary between retail pharmacies, online pharmacies, and mail-order services.
• Dosage and Quantity: The strength of the medication and the number of tablets dispensed per refill will affect the total price.
• Assistance Programs: Some patients may be eligible for manufacturer coupons or patient assistance programs that can help lower the cost of brand-name medications.